• OPEN AN ACCOUNT
Indian Indices
Sensex
82,496.41 464.60
( 0.57%)
Global Indices
Nasdaq
50,205.66 -574.76
(-1.13%)
Dow Jones
7,342.05 -19.48
(-0.26%)
Hang Seng
59,089.01 228.58
(0.39%)
Nikkei 225
10,545.68 -144.19
(-1.35%)
Forex
USD-INR
93.54 -0.42
(-0.44%)
EUR-INR
102.90 -0.55
(-0.53%)
GBP-INR
123.45 -0.54
(-0.44%)
JPY-INR
0.59 0.00
(-0.28%)

EQUITY - MARKET SCREENER

Titan Biotech Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524717
INE150C01029
36.69382
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
60.64
2135.91
EPS(TTM)
Face Value()
Div & Yield %
6.82
2
0.1
 

Cravatex consolidated net profit declines 11.49% in the September 2026 quarter
Nov 03,2026
Net profit of Cravatex declined 11.49% to Rs 4.62 crore in the quarter ended September 2026 as against Rs 5.22 crore during the previous quarter ended September 2025. Sales rose 3.91% to Rs 53.46 crore in the quarter ended September 2026 as against Rs 51.45 crore during the previous quarter ended September 2025.

ParticularsQuarter Ended
Sep. 2026Sep. 2025% Var.
Sales53.4651.45 4
OPM %5.725.35 -
PBDT6.356.46 -2
PBT5.976.08 -2
NP4.625.22 -11